Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome


KESKİN O. , Wedemeyer H., TÜZÜN A. E. , Zachou K., Deda X., Dalekos G. N. , ...Daha Fazla

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, cilt.13, ss.2342-2351, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 13 Konu: 13
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.cgh.2015.05.029
  • Dergi Adı: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
  • Sayfa Sayıları: ss.2342-2351

Özet

BACKGROUND & AIMS: Interferon is the only effective treatment for chronic hepatitis D virus (HDV) infection. No rules have been set for stopping treatment based on viral kinetics. We analyzed data from an international study of hepatitis D treatment to identify factors associated with outcomes of pegylated interferon treatment, with and without adefovir.